India’s Lupin Says Ready To Present Mandideep Plan To U.S. FDA; Push On Novel Drug Delivery, Biosimilars And Indian Market To Propel Revenue Growth

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.